Core Points - The Annual General Meeting of ChemoMetec A/S was held on 9 October 2025, where the Board of Directors' report and the annual report for 2024/25 were approved [1] - A dividend of DKK 7 per share was approved for distribution [2] - The Board of Directors will continue to consist of 5 members, with Niels Thestrup, Martin Glensbjerg, Kristine Færch, Betina Hagerup, and Peter Reich re-elected [2] - Deloitte was re-elected as the company's auditor, and the remuneration report was approved [3] - The Board of Directors was granted authority to acquire treasury shares [3] - A statutory board meeting was held post-general meeting, re-electing Niels Thestrup as chairman and Martin Glensbjerg as deputy chairman [4] Company Overview - ChemoMetec develops, manufactures, and markets instruments for cell counting and various measurements, serving the pharmaceutical, biotech, and agricultural industries globally [5] - The company was founded in 1997 and is listed on Nasdaq OMX Copenhagen [6]
Procedure of the Annual General Meeting
Globenewswire·2025-10-09 20:01